Question

A client with schizophrenia is receiving intramuscular injections of fluphenazine decanoate. After therapy is initiated, dystonia develops. What clinical manifestations does the nurse document during the assessment?

a. Akathisia
b. Torticollis
c. Shuffling gait
d. Masklike facies
e. Oculogyric crisis

Answer 1

Dystonia is a movement disorder characterized by involuntary muscle contractions. Clinical manifestations of dystonia in a client with schizophrenia receiving fluphenazine decanoate can include akathisia, torticollis, and masklike facies.

Step-by-step explanation:

Dystonia is a movement disorder characterized by involuntary muscle contractions that cause repetitive or twisting movements, making it difficult to control one's movements. In the case of a client with schizophrenia receiving intramuscular injections of fluphenazine decanoate, dystonia can be a side effect of the medication. The nurse would document clinical manifestations such as:

1. Akathisia: Restlessness and an inability to sit still.
2. Torticollis: Involuntary contraction of neck muscles leading to abnormal head positioning.
3. Masklike facies: Reduced facial expressions and facial stiffness.

The development of dystonia can occur due to the blocking effect of fluphenazine decanoate on dopamine receptors in the basal ganglia, disrupting the normal control of movement.